Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03078387
Other study ID # Bilateral retinal emboli
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 31, 2006
Est. completion date December 31, 2018

Study information

Verified date April 2019
Source Dr. S.S. Michel Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study shows how careful ophthalmic examination of two patients showed signs of simultaneous bilateral retinal emboli. Starting from this point significant, life threatening, underlying reasons were found and treated.


Description:

Two patients were found to have signs of simultaneous bilateral retinal emboli. One patient was asymptomatic and routine ophthalmic examination showed bilateral retinal hemorrhages and exudates close to both optic discs. This patient was on anti-coagulant treatment for atrial fibrillation. The finding of bilateral signs of retinal emboli necessitated immediate blood tests and dose adjustments of her medication.

The second case did not have general symptoms other than mild evening chills and her eye examination again was the start point of intensive investigation to find the reason of her bilateral retinal emboli. Ultrasound studies revealed a life threatening reason that was urgently treated.


Recruitment information / eligibility

Status Completed
Enrollment 2
Est. completion date December 31, 2018
Est. primary completion date January 29, 2013
Accepts healthy volunteers No
Gender All
Age group 30 Years to 80 Years
Eligibility Inclusion Criteria:

- any patient who is found to have sure signs of bilateral retinal emboli.

Exclusion Criteria:

- all other bilateral retinal diseases.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
imaging
imaging before and after treatment

Locations

Country Name City State
Canada Dr. S.S. Michel Clinic Edmonton Alberta

Sponsors (1)

Lead Sponsor Collaborator
Dr. Shawkat Michel

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary The extreme significance of immediate investigation of cases of bilateral retinal emboli (non-diabetic bilateral posterior pole retinal nerve fiber or pre-retinal hemorrhages). Patients that are noticed to have signs of bilateral retinal emboli (bilateral retinal nerve fiber layer hemorrhages or bilateral pre-retinal hemorrhages and sometimes bilateral soft exudates) may be asymptomatic or have very mild symptoms. However these patients must be immediately and, if needed, intensively investigated to find the source of these emboli. The extremely important point of this study is these patients usually have life threatening conditions that should be found out and treated in time. through study completion, an average of one year
See also
  Status Clinical Trial Phase
Completed NCT00154388 - Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases Phase 2